Retail Food Equivalents for PosteOral Immunotherapy Dosing in the Omalizumab as Monotherapy and as Adjunct Therapy to Multi-Allergen Oral Immunotherapy in Food-Allergic Children and Adults (OUtMATCH) Clinical Trial

被引:10
|
作者
Groetch, Marion [1 ]
Mudd, Kim [2 ]
Woch, Margaret [3 ]
Schaible, Allison [1 ]
Gray, Brianna E. [4 ]
Babineau, Denise C. [5 ]
Bird, J. Andrew [6 ]
Jones, Stacie [7 ,8 ]
Kim, Edwin H. [9 ]
Lanser, Bruce J. [10 ]
Poyser, Julian [11 ]
Rogers, Nicole [5 ]
Shreffler, Wayne [4 ]
Sicherer, Scott [1 ]
Spergel, Amanda K. Rudman
Spergel, Jonathan
Vickery, Brian P.
Chinthrajah, R. Sharon [3 ]
Wood, Robert [2 ]
机构
[1] Icahn Sch Med Mt Sinai, Jaffe Food Allergy Inst, Div Pediat Allergy & Immunol, One Gustave L Levy Pl, Box 1198, New York, NY 10029 USA
[2] Johns Hopkins Univ, Div Pediat Allergy & Immunol, Sch Med, Baltimore, MD USA
[3] Stanford Univ, Sch Med, Sean N Parker Ctr Allergy & Asthma Res, Stanford, CA USA
[4] Massachusetts Gen Hosp, Translat & Clin Res Ctr, Boston, MA USA
[5] Rho Inc, Durham, NC USA
[6] Univ Texas Southwestern Med Ctr, Dept Pediat, Div Allergy & Immunol, Dallas, TX USA
[7] Univ Arkansas Med Sci, Dept Pediat, Div Allergy & Immunol, Little Rock, AR USA
[8] Arkansas Childrens Hosp, Little Rock, AR USA
[9] Univ N Carolina, Dept Pediat, Div Pediat Allergy & Immunol, Sch Med, Chapel Hill, NC USA
[10] Natl Jewish Hlth, Dept Pediat, Denver, CO USA
[11] Natl Inst Allergy & Infect Dis, Div Allergy Immunol & Transplantat, NIH, Bethesda, MD USA
基金
美国国家卫生研究院;
关键词
Oral immunotherapy; OUtMATCH; Consortium for Food Allergy Research; Omalizumab; Retail food equivalents; Allergens; Diet; Nutrition; Food allergy; EGG ALLERGY; MILK; GUIDELINES;
D O I
10.1016/j.jaip.2022.10.022
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
BACKGROUND: Patients with food allergy may be advised to introduce specific foods into their diets, both to increase tolerance gradually and as next steps after completing oral immunotherapy or other therapeutic interventions. However, the safe use of retail foods depends on the ability to establish the specific allergen protein content of these foods.OBJECTIVE: To develop a systematic approach to estimate the protein content of peanut, milk, egg, wheat, cashew, hazelnut, and walnut in a variety of retail food equivalents for each allergen and associated patient education materials. METHOD: We created an algorithm that used a multistep process with information from product food labels, nutrient databases, independent weighing and measuring of foods, and information provided by manufacturers, including certificates of analysis, and e-mail communication to estimate the allergen protein content of multiple retail foods for each of seven allergens. Once a variety of retail food equivalents for each allergen and allergen serving size was determined, we developed participant education handouts, which were reviewed by study teams at 10 food allergy centers, the National Institute of Allergy and Infectious Diseases, and the Consortium for Food Al-lergy Research coordinating center. After 1 year of use, multiple queries were addressed and the retail food equiva-lents and educational materials were reviewed and edited. RESULTS: We identified a variety of retail food equivalents for seven allergens at six serving sizes, and created 48 unique patient education materials.CONCLUSION: Our results provide extensive guidance on a variety of retail equivalents for seven foods, and a method to estimate retail food protein equivalents systematically with ongoing reassessment. (c) 2022 American Academy of Allergy, Asthma & Immunology (J Allergy Clin Immunol Pract 2023;11:572-80)
引用
收藏
页码:572 / 580.e2
页数:11
相关论文
共 4 条
  • [1] Alternative dosing of omalizumab as an adjunct therapy during multiallergen oral immunotherapy in food allergic patients
    Sindher, Sayantani B.
    Long, Andrew J.
    Purington, Natasha
    Kumar, Divya
    Scheiber, Alexandra
    O'Laughlin, Katherine
    Woch, Margaret
    Tan, Tiffany
    Chinthrajah, R. Sharon
    Zedeck, Stacey Skura
    Lloret, Maria I. Garcia
    Nadeau, Kari C.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 143 (02) : AB245 - AB245
  • [2] A phase 2 randomized controlled study using omalizumab as an adjunct therapy during multi-allergen oral immunotherapy in food allergic individuals to test long-term outcomes
    Chinthrajah, R. S.
    Andorf, S.
    Purington, N.
    Kumar, D.
    Long, A.
    O'Laughlin, K.
    Sicherer, S.
    Sampson, H.
    Cianferoni, A.
    Whitehorn, T. B.
    Petroni, D.
    Makhija, M.
    Robison, R. G.
    Lierl, M.
    Logsdon, S.
    Desai, M.
    Galli, S. J.
    Assa'ad, A.
    Pongracic, J.
    Spergel, J. M.
    Tam, J.
    Tilles, S.
    Wang, J.
    Nadeau, K.
    ALLERGY, 2019, 74 : 798 - 799
  • [3] The multi-allergen oral immunotherapy: A new harder, faster, better, safer option for the children with multiple food allergies?
    Bradatan, E.
    Caimmi, D.
    Correard, A. -K.
    Braun, C.
    REVUE FRANCAISE D ALLERGOLOGIE, 2024, 64
  • [4] \ Egg Oral Immunotherapy (OIT) Induces Clinical Desensitization in a Double-Blind, Placebo-Controlled (DBPC) Trial in Egg Allergic Children from the Consortium of Food Allergy Research (CoFAR)
    Jones, S. M.
    Fleischer, D. M.
    Sicherer, S. H.
    Wood, R. A.
    Lindblad, R.
    Stablein, D.
    Liu, A. H.
    Shreffler, W.
    Leung, D. Y. M.
    Sampson, H. A.
    Burks, A. W.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2010, 125 (02) : AB357 - AB357